These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. (3SR,4aRS,6SR,8aRS)-6-(1H-tetrazol-5-yl)decahydroisoquinoline-3-carboxylic acid, a novel, competitive, systemically active NMDA and AMPA receptor antagonist. Ornstein PL; Arnold MB; Allen NK; Leander JD; Tizzano JP; Lodge D; Schoepp DD J Med Chem; 1995 Dec; 38(25):4885-90. PubMed ID: 8523401 [TBL] [Abstract][Full Text] [Related]
3. Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activity. Ornstein PL; Arnold MB; Allen NK; Bleisch T; Borromeo PS; Lugar CW; Leander JD; Lodge D; Schoepp DD J Med Chem; 1996 May; 39(11):2232-44. PubMed ID: 8667366 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitution. Ornstein PL; Arnold MB; Allen NK; Bleisch T; Borromeo PS; Lugar CW; Leander JD; Lodge D; Schoepp DD J Med Chem; 1996 May; 39(11):2219-31. PubMed ID: 8667365 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antagonism of AMPA receptor activation by (3S, 4aR, 6R, 8aR)-6-[2-(1(2)H-tetrazole-5-yl) ethyl] decahydroisoquinoline-3-carboxylic acid. Schoepp DD; Lodge D; Bleakman D; Leander JD; Tizzano JP; Wright RA; Palmer AJ; Salhoff CR; Ornstein PL Neuropharmacology; 1995 Sep; 34(9):1159-68. PubMed ID: 8532186 [TBL] [Abstract][Full Text] [Related]
6. The neuroprotective effects of the decahydroisoquinoline, LY 215490; a novel AMPA antagonist in focal ischaemia. Gill R; Lodge D Neuropharmacology; 1994 Dec; 33(12):1529-36. PubMed ID: 7760975 [TBL] [Abstract][Full Text] [Related]
7. Supraspinal and spinal alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid and N-methyl-D-aspartate glutamatergic control of the micturition reflex in the urethane-anesthetized rat. Yoshiyama M; de Groat WC Neuroscience; 2005; 132(4):1017-26. PubMed ID: 15857706 [TBL] [Abstract][Full Text] [Related]
8. Selective protection against AMPA- and kainate-evoked neurotoxicity by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahyd roisoquinoline- 3-carboxylic acid (LY293558) and its racemate (LY215490). Schoepp DD; Salhoff CR; Fuson KS; Sacaan AI; Tizzano JP; Ornstein PL; May PC J Neural Transm (Vienna); 1996; 103(8-9):905-16. PubMed ID: 9013384 [TBL] [Abstract][Full Text] [Related]
9. The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia. Gill R Cerebrovasc Brain Metab Rev; 1994; 6(3):225-56. PubMed ID: 7529037 [TBL] [Abstract][Full Text] [Related]